Un caso de seguridad de despliegue para la diagnosis de cáncer de próstata asistida por IA.
PMID: 40345136 ·
Y, a, n, , J, i, a, ;, , C, l, a, r, e, , V, e, r, r, i, l, l, ;, , K, i, e, r, o, n, , W, h, i, t, e, ;, , M, o, n, i, c, a, , D, o, l, t, o, n, ;, , M, a, r, g, a, r, e, t, , H, o, r, t, o, n, ;, , M, u, f, a, d, d, a, l, , J, a, f, f, e, r, j, i, ;, , I, b, r, a, h, i, m, , H, a, b, l, i
Publicidad
Resumen
Deep learning (DL) has the potential to deliver significant clinical benefits. In recent years, an increasing number of DL-based systems have been approved by the relevant regulators, e.g. FDA. Although obtaining regulatory approvals is a prerequisite to deploy such systems for real world use, it may not be sufficient. Regulatory approvals give confidence in the development process for such systems, but new hazardous events can arise depending on how the systems have been deployed in the intende
Publicidad
Fuente oficial
Ver en PubMed →Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.